N/A N=20 Randomized Supportive Care

Speeko for Elderspeak: A Self-Monitoring App to Improve Nursing Home Communication

Dementia · Staff Attitude

Bottom Line

View on ClinicalTrials.gov: NCT04064164 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2025

Primary outcome: Primary: Change in Elderspeak Measured by Diminutives Detected in Participant's Recorded Speech. — 0.03; 0.00; 0.00; 0.01 Diminutive Use per Utterance

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Speeko for Elderspeak (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Kansas Medical Center
Primary completion: Apr 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Elderspeak Measured by Diminutives Detected in Participant's Recorded Speech.	0.03; 0.00; 0.00; 0.01; 0.01; 0.00	—
SECONDARY Acceptability as Measured by System Usability Scale.	69.9	—
SECONDARY Evaluate the App Cost by Measuring Wages Per Hour by NH Role and Costs Associated With the Speeko for Elderspeak Application.	—	—

Summary

This study will test feasibility and preliminary effects of an automated and performance-based feedback app (Speeko for Elderspeak) that detects and reports the use of diminutives (terms of endearment such as honey, dearie, and sweetie), prevalent elderspeak terms linked to BPSD. Building on proof of concept established in the laboratory, the app will demonstrate feasibility at the point-of-care. Next, a clinical trial (N= 6NHs) will be conducted to test preliminary efficacy of the app for amplifying reductions in diminutives use for NH staff completing the CHATO training (3 online modules).

Eligibility Criteria

Inclusion Criteria

CNAs who are age 18 or older
Permanent employees
Fluent in English

Exclusion Criteria

CNAs younger than 18 or
CNAs who are not fluent in English.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04064164). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.